Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$199K Hold
1,665
0.01% 223
2025
Q4
$227K Hold
1,665
0.01% 234
2025
Q3
$246K Sell
1,665
-2,062
-55% -$286K 0.01% 211
2025
Q2
$481K Sell
3,727
-1,851
-33% -$224K 0.02% 199
2025
Q1
$666K Sell
5,578
-1,814
-25% -$225K 0.03% 188
2024
Q4
$858K Sell
7,392
-28
-0.4% -$3.54K 0.01% 186
2024
Q3
$1M Sell
7,420
-1,545
-17% -$207K 0.04% 159
2024
Q2
$1.22M Buy
8,965
+3,594
+67% +$489K 0.06% 129
2024
Q1
$694K Buy
+5,371
New +$649K 0.03% 188

Other funds holding XYL

BNP Paribas's XYL Position: Q1 2026 in Review

BNP Paribas held its Xylem (XYL) position steady in Q1 2026 at 1,665 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #223.

BNP Paribas first reported a position in XYL in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.22M in Q2 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • BNP Paribas held 1,665 shares of Xylem worth $199K as of Q1 2026.
  • BNP Paribas left its Xylem share count unchanged in Q1 2026.
  • Xylem made up 0.01% of BNP Paribas's portfolio in Q1 2026, its #223 holding.
  • BNP Paribas first reported a position in Xylem in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Xylem position peaked at $1.22M in Q2 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.